- Home
- GWRS vs DRTS Comparison
GWRS vs DRTS Comparison
Compare GWRS & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRS
- DRTS
- Stock Information
- Founded
- GWRS 2003
- DRTS 2015
- Country
- GWRS United States
- DRTS Israel
- Employees
- GWRS N/A
- DRTS N/A
- Industry
- GWRS Water Supply
- DRTS Medical/Dental Instruments
- Sector
- GWRS Utilities
- DRTS Health Care
- Exchange
- GWRS Nasdaq
- DRTS Nasdaq
- Market Cap
- GWRS 265.4M
- DRTS 300.2M
- IPO Year
- GWRS 2010
- DRTS N/A
- Fundamental
- Price
- GWRS $10.85
- DRTS $4.13
- Analyst Decision
- GWRS
- DRTS Strong Buy
- Analyst Count
- GWRS 0
- DRTS 1
- Target Price
- GWRS N/A
- DRTS $9.00
- AVG Volume (30 Days)
- GWRS 63.4K
- DRTS 62.8K
- Earning Date
- GWRS 11-05-2025
- DRTS 11-18-2025
- Dividend Yield
- GWRS 2.83%
- DRTS N/A
- EPS Growth
- GWRS N/A
- DRTS N/A
- EPS
- GWRS 0.22
- DRTS N/A
- Revenue
- GWRS $54,270,000.00
- DRTS N/A
- Revenue This Year
- GWRS $8.22
- DRTS N/A
- Revenue Next Year
- GWRS $8.43
- DRTS N/A
- P/E Ratio
- GWRS $49.31
- DRTS N/A
- Revenue Growth
- GWRS 4.33
- DRTS N/A
- 52 Week Low
- GWRS $9.27
- DRTS $2.11
- 52 Week High
- GWRS $13.98
- DRTS $4.69
- Technical
- Relative Strength Index (RSI)
- GWRS 70.10
- DRTS 58.49
- Support Level
- GWRS $9.98
- DRTS $4.07
- Resistance Level
- GWRS $10.33
- DRTS $4.50
- Average True Range (ATR)
- GWRS 0.26
- DRTS 0.21
- MACD
- GWRS 0.06
- DRTS -0.02
- Stochastic Oscillator
- GWRS 84.49
- DRTS 39.13
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.